All Publications

All publications

The HARMONY Alliance Foundation’s publications reflect the shared expertise and collaborative efforts of our research community. They present innovative methodologies and data-driven insights that help address some of the most urgent challenges in haematological malignancies.

Publications

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance Platform

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

Real-world evaluation of UK high hyper diploidy profile using a large cohort of patients provided by HARMONY data platform

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in Onco-Hematology

Different prognostic impact of recurrent gene mutations in CLL depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

Second Revision of the International Staging System (R2-ISS) for Overall Survival in MM: A European Myeloma Network (EMN) Report Within the HARMONY Project

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology: Added Value Framework for Hematologic Malignancies

All publications

Publications

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance Platform

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

Real-world evaluation of UK high hyper diploidy profile using a large cohort of patients provided by HARMONY data platform

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in Onco-Hematology

Different prognostic impact of recurrent gene mutations in CLL depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

Second Revision of the International Staging System (R2-ISS) for Overall Survival in MM: A European Myeloma Network (EMN) Report Within the HARMONY Project

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology: Added Value Framework for Hematologic Malignancies

Contact

Executive Office

Follow us

All publications

Publications

Machine learning risk stratification strategy for multiple myeloma: Insights from the EMN–HARMONY Alliance Platform

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance

Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

Real-world evaluation of UK high hyper diploidy profile using a large cohort of patients provided by HARMONY data platform

Covering Hierarchical Dirichlet Mixture Models on binary data to enhance genomic stratifications in Onco-Hematology

Different prognostic impact of recurrent gene mutations in CLL depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY

Second Revision of the International Staging System (R2-ISS) for Overall Survival in MM: A European Myeloma Network (EMN) Report Within the HARMONY Project

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology: Added Value Framework for Hematologic Malignancies

Contact

Executive Office

Follow us

Spain